Stroke study backs Radiant's brain cooling technology:
This article was originally published in Clinica
Executive Summary
Radiant Medical has reported promising results from a trial to assess its Reprieve endovascular temperature therapy system in treating ischaemic stroke patients through cooling. The 40-patient study, COOL-AID II, which the firm claims is the first to use the blood-cooling technology in stroke patients, showed that cooling patients' brains to 33 degrees C (mild hypothermia) for 24 ours led to a trend towards reduced brain tissue damage, says the Redwood City, California firm.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.